BRAWN BIOTECH LTD.

Company Profile

BRAWN BIOTECH LTD. had its IPO on under the ticker symbol BRAWN.

The company operates in the sector and industry. BRAWN BIOTECH LTD. has a staff strength of 0 employees.

Stock update

Shares of BRAWN BIOTECH LTD. opened at ₹23.92 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹23.92 - ₹23.92, and closed at ₹23.92.

This is a 0% increase from the previous day's closing price.

A total volume of 0 shares were traded at the close of the day’s session.

In the last one week, shares of BRAWN BIOTECH LTD. have increased by 0%.

BRAWN BIOTECH LTD.'s Key Ratios

BRAWN BIOTECH LTD. has a market cap of ₹67.81 million, indicating a price to book ratio of 0.813 and a price to sales ratio of 0.3563.

In the last 12-months BRAWN BIOTECH LTD.’s revenue was ₹0 with a gross profit of ₹74.70 million and an EBITDA of ₹0. The EBITDA ratio measures BRAWN BIOTECH LTD.'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, BRAWN BIOTECH LTD.’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q1, BRAWN BIOTECH LTD.’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

BRAWN BIOTECH LTD.’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into BRAWN BIOTECH LTD.’s profitability.

BRAWN BIOTECH LTD. stock is trading at a EV to sales ratio of 0.2106 and a EV to EBITDA ratio of -2.1256. Its price to sales ratio in the trailing 12-months stood at 0.3563.

BRAWN BIOTECH LTD. stock pays annual dividends of ₹1 per share, indicating a yield of 4.42% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

₹145.31 million

Total Liabilities

₹80.47 million

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

0%

BRAWN BIOTECH LTD. ended 2025 with ₹145.31 million in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹145.31 million while shareholder equity stood at ₹63.09 million.

BRAWN BIOTECH LTD. ended 2025 with ₹0 in deferred long-term liabilities, ₹80.47 million in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹4.39 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.

BRAWN BIOTECH LTD.’s total current assets stands at ₹133.99 million while long-term investments were ₹0 and short-term investments were ₹11.27 million. Its net receivables were ₹53.15 million compared to accounts payable of ₹64.69 million and inventory worth ₹47.91 million.

In 2025, BRAWN BIOTECH LTD.'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, BRAWN BIOTECH LTD. paid ₹0 in dividends in 2025.

Other key metrics

Current Trading Price

₹23.92

52-Week High

₹22.85

52-Week Low

₹14.36

Analyst Target Price

₹

BRAWN BIOTECH LTD. stock is currently trading at ₹23.92 per share. It touched a 52-week high of ₹22.85 and a 52-week low of ₹22.85. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹19.94 and 200-day moving average was ₹18.39 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.